FDA authorizes Roche drug for severely ill COVID-19 patients – Fox News
The Food and Drug Administration granted emergency approval to Roches Actemra (tocilizumab) to boost outcomes among hospitalized COVID-19 patients receiving oxygen and steroid medications.
Data from clinical trials among over 5,600 hospitalized patients…
